Tag:
Cameron Health
Latest Headlines
Latest Headlines
Boston Scientific's CEO: CRM business in active rebuilding mode
Boston Scientific's launch of new pacemaker products and a pending acquisition will be crucial toward reversing the company's declines in cardiac rhythm management revenue as well as pushing ahead with global expansion, CEO Hank Kucheman says.
FDA panel gives Cameron Health good news on implantable ICD
Good news for Cameron Health (and Boston Scientific ($BSX)). An FDA panel voted Thursday 7-1 to recommend approval of the company's implantable defibrillator.
FDA panel to evaluate HeartWare International's blood pump
HeartWare International's blood pump and Cameron Health's under-the-skin defibrillator go before an FDA panel of experts this week whose recommendation could make or break their chances for marketing approval.
BSX grabs ICD startup Cameron Health for $150M+
Boston Scientific ( $BSX ) is getting serious about shocking its defibrillator sales back to life.
